HS
HighVista Strategies’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
10,909
-10,594
| -49% | -$1.11M | 0.42% | 101 |
|
|
2025
Q1 | $2.51M | Buy |
21,503
+4,379
| +26% | +$511K | 0.97% | 19 |
|
|
2024
Q4 | $1.45M | Sell |
17,124
-24,418
| -59% | -$2.07M | 0.54% | 74 |
|
|
2024
Q3 | $3.73M | Sell |
41,542
-20,650
| -33% | -$1.86M | 1.29% | 17 |
|
|
2024
Q2 | $5.01M | Buy |
62,192
+13,665
| +28% | +$1.1M | 1.83% | 5 |
|
|
2024
Q1 | $3.87M | Sell |
48,527
-13,736
| -22% | -$1.1M | 1.38% | 17 |
|
|
2023
Q4 | $4.96M | Buy |
62,263
+5,299
| +9% | +$422K | 1.8% | 5 |
|
|
2023
Q3 | $3.98M | Buy |
56,964
+7,564
| +15% | +$529K | 1.84% | 10 |
|
|
2023
Q2 | $3.55M | Sell |
49,400
-11,374
| -19% | -$817K | 1.62% | 12 |
|
|
2023
Q1 | $3.75M | Buy |
60,774
+5,650
| +10% | +$348K | 3.05% | 4 |
|
|
2022
Q4 | $4.25M | Buy |
55,124
+38,238
| +226% | +$2.95M | 2.52% | 6 |
|
|
2022
Q3 | $753K | Buy |
+16,886
| New | +$753K | 0.43% | 63 |
|
|
2021
Q2 | – | Sell |
-11,664
| Closed | -$660K | – | 124 |
|
|
2021
Q1 | $660K | Buy |
11,664
+651
| +6% | +$36.8K | 0.49% | 47 |
|
|
2020
Q4 | $897K | Buy |
11,013
+5,001
| +83% | +$407K | 0.57% | 36 |
|
|
2020
Q3 | $428K | Sell |
6,012
-929
| -13% | -$66.1K | 0.31% | 63 |
|
|
2020
Q2 | $571K | Buy |
+6,941
| New | +$571K | 0.47% | 15 |
|